Enlon-Plus Related Published Studies
Well-designed clinical trials possibly related to Enlon-Plus (Edrophonium / Atropine)
Low-dose naltrexone for the treatment of fibromyalgia: Findings of a small,
randomized, double-blind, placebo-controlled, counterbalanced, crossover trial
assessing daily pain levels. [2013]
Reduction in Healthcare and Societal Resource Utilization Associated with Cladribine Tablets in Patients with Relapsing-Remitting Multiple Sclerosis: Analysis of Economic Data from the CLARITY Study. [2012.01.01]
Randomized clinical trial of a brief psychological intervention to increase walking in patients with intermittent claudication. [2012.01]
Salivary cortisol profiles in patients remitted from recurrent depression: One-year follow-up of a mindfulness-based cognitive therapy trial. [2012.01]
Conservative versus surgical management of idiopathic normal pressure hydrocephalus: a prospective double-blind randomized controlled trial: study protocol. [2012]
Effectiveness of core stability exercises and recovery myofascial release massage on fatigue in breast cancer survivors: a randomized controlled clinical trial. [2012]
Periarticular infiltration of 0.25% bupivacaine on top of femoral nerve block and
intrathecal morphine improves quality of pain control after total knee
arthroplasty: a randomized double-blind placebo controlled clinical trial. [2012]
Randomized controlled trial of interventions for young people at ultra-high risk
of psychosis: twelve-month outcome. [2012]
L-methylfolate as adjunctive therapy for SSRI-resistant major depression: results
of two randomized, double-blind, parallel-sequential trials. [2012]
Effect of abiraterone acetate and prednisone compared with placebo and prednisone
on pain control and skeletal-related events in patients with metastatic
castration-resistant prostate cancer: exploratory analysis of data from the
COU-AA-301 randomised trial. [2012]
Effect of a monoclonal antibody to PCSK9 on low-density lipoprotein cholesterol
levels in statin-intolerant patients: the GAUSS randomized trial. [2012]
Atorvastatin with or without an antibody to PCSK9 in primary
hypercholesterolemia. [2012]
Anticholinergic therapy vs. onabotulinumtoxina for urgency urinary incontinence. [2012]
Estrogen plus progestin and colorectal cancer incidence and mortality. [2012]
Pulsed Nd: YAG laser induces pulpal analgesia: a randomized clinical trial. [2012]
Troponin I release after intravenous treatment with high furosemide doses plus
hypertonic saline solution in decompensated heart failure trial (Tra-HSS-Fur). [2012]
Evaluation of a multi-herb supplement for erectile dysfunction: a randomized
double-blind, placebo-controlled study. [2012]
Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus
long-acting beta(2)-agonists for chronic obstructive pulmonary disease. [2012]
Cediranib with mFOLFOX6 versus bevacizumab with mFOLFOX6 as first-line treatment
for patients with advanced colorectal cancer: a double-blind, randomized phase
III study (HORIZON III). [2012]
Efficacy and tolerability of diphenyl-dimethyl-dicarboxylate plus garlic oil in
patients with chronic hepatitis. [2012]
Effect on corneal endothelial cell loss during phacoemulsification: fortified
balanced salt solution versus Ringer lactate. [2012]
Comparison of risk factor reduction and tolerability of a full-dose polypill
(with potassium) versus low-dose polypill (polycap) in individuals at high risk
of cardiovascular diseases: the Second Indian Polycap Study (TIPS-2)
investigators. [2012]
Vigabatrin versus carbamazepine monotherapy for epilepsy. [2012]
Long term hormone therapy for perimenopausal and postmenopausal women. [2012]
Lipid profiles within the SABRE trial of anastrozole with and without
risedronate. [2012]
Sunitinib plus erlotinib for the treatment of advanced/metastatic non-small-cell
lung cancer: a lead-in study. [2012]
Comparing alumina-reduced and conventional surface grit-blasted acetabular cups
in primary THA: early results from a randomised clinical trial. [2012]
Double-blind placebo-controlled randomized efficacy and safety trial of add-on
treatment of dimebon plus risperidone in schizophrenic patients during transition
from acute psychotic episode to remission. [2012]
Nortriptyline for treating enuresis in ADHD--a randomized double-blind controlled
clinical trial. [2012]
Intravenous lidocaine for the treatment of background or procedural burn pain. [2012]
AMG 386 in combination with sorafenib in patients with metastatic clear cell
carcinoma of the kidney: a randomized, double-blind, placebo-controlled, phase 2
study. [2012]
Delamanid for multidrug-resistant pulmonary tuberculosis. [2012]
Effect of alginate supplementation on weight loss in obese subjects completing a
12-wk energy-restricted diet: a randomized controlled trial. [2012]
Day 3 embryo selection by metabolomic profiling of culture medium with
near-infrared spectroscopy as an adjunct to morphology: a randomized controlled
trial. [2012]
Randomised clinical trial: simvastatin as adjuvant therapy improves significantly
the Helicobacter pylori eradication rate--a placebo-controlled study. [2012]
Sorafenib in locally advanced or metastatic breast cancer. [2012]
[A pilot trial on the treatment of gastroesophageal reflux-related cough in
infants]. [Article in Chinese] [2012]
Efficacy of human rotavirus vaccine against severe gastroenteritis in Malawian
children in the first two years of life: a randomized, double-blind, placebo
controlled trial. [2012]
Minocycline benefits negative symptoms in early schizophrenia: a randomised
double-blind placebo-controlled clinical trial in patients on standard treatment. [2012]
Endometrial shedding effect on conception and live birth in women with polycystic
ovary syndrome. [2012]
Blood pressure lowering efficacy of potassium-sparing diuretics (that block the
epithelial sodium channel) for primary hypertension. [2012]
The effect of intravenous morphine on the level of spinal anesthesia with
lidocaine. [2012]
Evaluation of oral zinc sulfate effect on obsessive-compulsive disorder: a
randomized placebo-controlled clinical trial. [2012]
Factors associated with non-completion in a double-blind randomized controlled
trial of olanzapine plus sertraline versus olanzapine plus placebo for psychotic
depression. [2012]
Study protocol- Lumbar Epidural steroid injections for Spinal Stenosis (LESS): a
double-blind randomized controlled trial of epidural steroid injections for
lumbar spinal stenosis among older adults. [2012]
Rationale and design of MARQUEE: a phase III, randomized, double-blind study of
tivantinib plus erlotinib versus placebo plus erlotinib in previously treated
patients with locally advanced or metastatic, nonsquamous, non-small-cell lung
cancer. [2012]
Phase IV study comparing diurnal glycemic profile following the administration of
2 NPH plus regular human DNA recombinant insulin regimens in type 1 diabetes
mellitus (T1DM) adult patients. [2012]
Pemetrexed in combination with cisplatin versus cisplatin monotherapy in patients
with recurrent or metastatic head and neck cancer: final results of a randomized,
double-blind, placebo-controlled, phase 3 study. [2012]
A combination of high-dose vitamin C plus zinc for the common cold. [2012]
Effect of dalcetrapib plus pravastatin on lipoprotein metabolism and high-density
lipoprotein composition and function in dyslipidemic patients: results of a phase
IIb dose-ranging study. [2012]
Sumatriptan (subcutaneous route of administration) for acute migraine attacks in
adults. [2012]
Ketofol (mixture of ketamine and propofol) administration in electroconvulsive
therapy. [2012]
A double-blind placebo controlled trial of Ginkgo biloba added to risperidone in
patients with autistic disorders. [2012]
Botulinum toxin injection for hypertonicity of the upper extremity within 12
weeks after stroke: a randomized controlled trial. [2012]
Silybin combined with phosphatidylcholine and vitamin E in patients with
nonalcoholic fatty liver disease: a randomized controlled trial. [2012]
Quality of life in patients with advanced non-small-cell lung cancer given
maintenance treatment with pemetrexed versus placebo (H3E-MC-JMEN): results from
a randomised, double-blind, phase 3 study. [2012]
Transarterial chemoembolization plus sorafenib: a sequential therapeutic scheme
for HCV-related intermediate-stage hepatocellular carcinoma: a randomized
clinical trial. [2012]
Evaluation of masking study participants to intravitreal injections in a
randomized clinical trial. [2012]
A phase II, double-blind, randomised, placebo-controlled study of BMS945429
(ALD518) in patients with rheumatoid arthritis with an inadequate response to
methotrexate. [2012]
The DRD2/ANKK1 gene is associated with response to add-on dextromethorphan
treatment in bipolar disorder. [2012]
Randomised clinical trial: efficacy of a new synbiotic formulation containing
Lactobacillus paracasei B21060 plus arabinogalactan and xilooligosaccharides in
children with acute diarrhoea. [2012]
Apixaban versus enoxaparin for thromboprophylaxis after hip or knee replacement:
pooled analysis of major venous thromboembolism and bleeding in 8464 patients
from the ADVANCE-2 and ADVANCE-3 trials. [2012]
Bone density and structure in healthy postmenopausal women treated with
exemestane for the primary prevention of breast cancer: a nested substudy of the
MAP.3 randomised controlled trial. [2012]
Desmopressin and oxybutynin in monosymptomatic nocturnal enuresis: a randomized,
double-blind, placebo-controlled trial and an assessment of predictive factors. [2012]
Therapeutic effects of cerebrolysin added to risperidone in patients with
schizophrenia dominated by negative symptoms. [2012]
Lumbar drainage of cerebrospinal fluid after aneurysmal subarachnoid hemorrhage:
a prospective, randomized, controlled trial (LUMAS). [2012]
A phase II randomized study of cisplatin-pemetrexed plus either enzastaurin or
placebo in chemonaive patients with advanced non-small cell lung cancer. [2012]
Neoadjuvant anastrozole versus tamoxifen in patients receiving goserelin for
premenopausal breast cancer (STAGE): a double-blind, randomised phase 3 trial. [2012]
A double-blind, randomized, placebo-controlled, phase 2 study of maintenance
enzastaurin with 5-fluorouracil/leucovorin plus bevacizumab after first-line
therapy for metastatic colorectal cancer. [2012]
AZD9668, a neutrophil elastase inhibitor, plus ongoing budesonide/formoterol in
patients with COPD. [2012]
BEAM: a randomized phase II study evaluating the activity of bevacizumab in
combination with carboplatin plus paclitaxel in patients with previously
untreated advanced melanoma. [2012]
Randomized phase II trial of docetaxel plus prednisone in combination with
placebo or AT-101, an oral small molecule Bcl-2 family antagonist, as first-line
therapy for metastatic castration-resistant prostate cancer. [2012]
Buprenorphine 5, 10 and 20 mug/h Transdermal Patch: A Review of its Use in the Management of Chronic Non-Malignant Pain. [2011.12.24]
Nurse-led Disease Management for Hypertension Control in a Diverse Urban Community: a Randomized Trial. [2011.12.06]
Effect of Daily Text Messages on Oral Contraceptive Continuation: A Randomized Controlled Trial. [2011.12.02]
Aripiprazole plus divalproex for recently manic or mixed patients with bipolar I disorder: a 6-month, randomized, placebo-controlled, double-blind maintenance trial. [2011.12.02]
Benefit of exercise therapy for systolic heart failure in relation to disease severity and etiology-findings from the Heart Failure and A Controlled Trial Investigating Outcomes of Exercise Training study. [2011.12]
Efficacy of estrogen plus progestin on menopausal symptoms in women with systemic lupus erythematosus: A randomized, double-blind, controlled trial. [2011.12]
A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus. [2011.12]
Low-Dose Doxycycline Plus Additional Therapies may Lower Systemic Inflammation in Postmenopausal Women with Periodontitis. [2011.12]
Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial. [2011.12]
Evaluation of analgesic efficacy of intra-articular bupivacaine, bupivacaine plus fentanyl, and bupivacaine plus tramadol after arthroscopic knee surgery. [2011.12]
The responsiveness and correlation between Fugl-Meyer Assessment, Motor Status Scale, and the Action Research Arm Test in chronic stroke with upper-extremity rehabilitation robotic training. [2011.12]
Does acceptance and relationship focused behavior therapy contribute to bupropion outcomes? A randomized controlled trial of functional analytic psychotherapy and acceptance and commitment therapy for smoking cessation. [2011.12]
Effects of n-3 fatty acids on depressive symptoms and dispositional optimism after myocardial infarction. [2011.12]
A double-blind, randomized, controlled trial of fluoxetine plus quetiapine or clomipramine versus fluoxetine plus placebo for obsessive-compulsive disorder. [2011.12]
A randomized controlled trial for obesity and binge eating disorder: Low-energy-density dietary counseling and cognitive-behavioral therapy. [2011.12]
Postoperative care for Samter's triad patients undergoing endoscopic sinus surgery: A double-blinded, randomized controlled trial. [2011.12]
Less mammographic density after nasal versus oral administration of postmenopausal hormone therapy. [2011.12]
Lower Immunoglobulin G Antibody Responses to Pneumococcal Conjugate Vaccination at the Age of 2 Years after Previous Nasopharyngeal Carriage of Streptococcus pneumoniae. [2011.12]
Initial combined treatment with anticholinergics and alpha-blockers for men with lower urinary tract symptoms related to BPH and overactive bladder: a prospective, randomized, multi-center, double-blind, placebo-controlled study. [2011.12]
Randomized study of repaglinide alone and in combination with metformin in Chinese subjects with type 2 diabetes naive to oral antidiabetes therapy. [2011.12]
Randomized phase II trial of docetaxel plus prednisone in combination with placebo or AT-101, an oral small molecule Bcl-2 family antagonist, as first-line therapy for metastatic castration-resistant prostate cancer. [2011.11.29]
Web-based risk communication and planning in an obese population: exploratory study. [2011.11.24]
A randomized controlled trial evaluating a new 2-L PEG solution plus ascorbic acid vs 4-L PEG for bowel cleansing prior to colonoscopy. [2011.11.23]
Comparison of pemetrexed plus cisplatin with other first-line doublets in advanced non-small cell lung cancer (NSCLC): A combined analysis of three phase 3 trials. [2011.11.22]
Functional movement disorders: Successful treatment with a physical therapy rehabilitation protocol. [2011.11.21]
Randomized Placebo-Controlled Phase II Trial of Perifosine Plus Capecitabine As Second- or Third-Line Therapy in Patients With Metastatic Colorectal Cancer. [2011.11.20]
[Treatment of pulmonary fibrosis : New substances and new interventions.] [2011.11.19]
Progestogen levels, progesterone receptor gene polymorphisms, and mammographic density changes: results from the Postmenopausal Estrogen/Progestin Interventions Mammographic Density Study. [2011.11.18]
Effect of Pretreatment with Lactobacillus gasseri OLL2716 on First-line Helicobacter pylori Eradication Therapy. [2011.11.18]
|
